Join our Stock Market News Group at GetPaidIndia on Telegram and WhatsApp.

This website is purely ACADEMIC in nature and NOT a stock market recommendation service or a tip provider. No live data or feeds are provided and all information is historic only. Information is provided for ease of understanding for the purpose of learning. Accuracy of definitions etc is not mantained. I am not a SEBI or IRDA registered.

Torrent Pharmaceuticals Limited



From GetPaidIndia.com
Jump to:navigation, search

Technical Indicators

Date SuperTrend Trend Reversal PSAR Williams %R (14) CCI (20) ADX (14)
December 27, 2017 Bullish 1292.16 Bullish -22.59 Overbought (Bearish) +162 Strong Uptrend (Bullish) 27.78 (Neutral)

Chart Frequency: 1 Day; Chart Style: Heikin Ashi

SuperTrend Parameters: Period: 7; Multiplier: 3

Parabolic SAR: Minimum AF: 0.02; Maximum AF: 0.2

Financial Results

Earnings Per Share (Quarterly)(Standalone Basic EPS)

EPS 30 September 2016 30 June 2017 30 September 2017
9.96 4.97 9.31

Related Lesson: How much should be ideal Earnings Per Share?

Ratings / Rankings

Date Source Ranking Description
Mar 6 - 19, 2017 Dalal Street Investment Journal # 4 Super 50

Coverage / Ratings / Rankings

Date Source / Publication Category Ranking / Description / Comments
June 5, 2017 Geojit Insights Equity Fund Recommendations Buy; We expect company’s revenue/PAT to grow at a CAGR of 13.8%/20.3% during FY17-19E driven by strong domestic operations & key launches in the US. Notably, Torrent has one of the best return ratios in the pharma industry with RoEs in excess of 25%. Hence, we initiate Torrent Pharma with a BUY rating with a TP of Rs.1,538 based on 19x FY19E EPS. Hence, we initiate Torrent Pharma with a BUY rating based on 19x FY19E EPS.

Related Categories